{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:07:35Z","timestamp":1790687255281,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T00:00:00Z","timestamp":1615852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jctube.2021.100229","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T23:21:53Z","timestamp":1617319313000},"page":"100229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Audiological monitoring of patients undergoing multidrug resistant tuberculosis treatment at Jigme Dorji Wangchuk National Referral Hospital and Gidakom Hospital, Bhutan"],"prefix":"10.1016","volume":"23","author":[{"given":"Pelden","family":"Wangchuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tika","family":"Ram Adhikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaki","family":"Nima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuntsho","family":"Dendup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jctube.2021.100229_b0005","unstructured":"WHO Global tuberculosis report 2020. 2020."},{"key":"10.1016\/j.jctube.2021.100229_b0010","unstructured":"WHO, U., General Assembly High-Level Meeting on Ending TB."},{"key":"10.1016\/j.jctube.2021.100229_b0015","series-title":"surveillance and response: supplement to global tuberculosis report","author":"Organization","year":"2014"},{"key":"10.1016\/j.jctube.2021.100229_b0020","unstructured":"Organization, W.H., Global tuberculosis report 2013. 2013: World Health Organization."},{"key":"10.1016\/j.jctube.2021.100229_b0025","doi-asserted-by":"crossref","unstructured":"Selimoglu, E.J.C.p.d., Aminoglycoside-induced ototoxicity. 2007. 13(1): p. 119-126.","DOI":"10.2174\/138161207779313731"},{"key":"10.1016\/j.jctube.2021.100229_b0030","doi-asserted-by":"crossref","unstructured":"Sarin, R., et al., Second-line injectable induced ototoxicity in drug resistant tuberculosis: a systematic review of Indian studies. 2019. 66(2): p. 279-287.","DOI":"10.1016\/j.ijtb.2019.04.007"},{"key":"10.1016\/j.jctube.2021.100229_b0035","unstructured":"Adoga, A., et al., Treatment of Multi-Drug Resistant Tuberculosis and the Associated Hearing Loss in Jos-North Central Nigeria. 2019. 1(4): p. 315-321."},{"key":"10.1016\/j.jctube.2021.100229_b0040","unstructured":"Organization, W.H., Addressing the rising prevalence of hearing loss. 2018."},{"issue":"1","key":"10.1016\/j.jctube.2021.100229_b0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3126\/saarctb.v17i1.25027","article-title":"Epidemiology of drug resistant tuberculosis in samtse general hospital, Bhutan: a retrospective study","volume":"17","author":"Dorji","year":"2019","journal-title":"SAARC J Tuberculosis, Lung Dis HIV\/AIDS"},{"key":"10.1016\/j.jctube.2021.100229_b0050","unstructured":"Vos, T., et al., Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. 2015. 386(9995): p. 743-800."},{"key":"10.1016\/j.jctube.2021.100229_b0055","unstructured":"Organization, W.H., Global costs of unaddressed hearing loss and cost-effectiveness of interventions: a WHO report, 2017. 2017: World Health Organization."},{"key":"10.1016\/j.jctube.2021.100229_b0060","unstructured":"James, S.L., et al., Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. 2018. 392(10159): p. 1789-1858."},{"key":"10.1016\/j.jctube.2021.100229_b0065","doi-asserted-by":"crossref","unstructured":"Stavroulaki, P., et al., Evoked otoacoustic emissions\u2014an approach for monitoring cisplatin induced ototoxicity in children. 2001. 59(1): p. 47-57.","DOI":"10.1016\/S0165-5876(01)00455-4"},{"key":"10.1016\/j.jctube.2021.100229_b0070","doi-asserted-by":"crossref","unstructured":"Reavis, K.M., et al., Factors Affecting Sensitivity of Distortion-Product Otoacoustic Emissions to Ototoxic Hearing Loss. 2008. 29(6): p. 875-893.","DOI":"10.1097\/AUD.0b013e318181ad99"},{"key":"10.1016\/j.jctube.2021.100229_b0075","doi-asserted-by":"crossref","unstructured":"Konrad-Martin, D., et al., Audiological monitoring of patients receiving ototoxic drugs. 2005. 9(1): p. 17-22.","DOI":"10.1044\/hhd9.1.17"},{"key":"10.1016\/j.jctube.2021.100229_b0080","doi-asserted-by":"crossref","unstructured":"Dayal, V.S., et al., Combined effects of noise and kanamycin. 1971. 80(6): p. 897-902.","DOI":"10.1177\/000348947108000616"},{"issue":"1","key":"10.1016\/j.jctube.2021.100229_b0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.47811\/bhj.96","article-title":"Prevalence of Occupational noise induced hearing loss (ONIHL) among industrial workers in","volume":"6","author":"Wangchuk","year":"2020","journal-title":"Bhutan"},{"issue":"7","key":"10.1016\/j.jctube.2021.100229_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1044\/leader.FTR1.10072005.1","article-title":"Ototoxicity: early detection and monitoring","volume":"10","author":"Konrad-Martin","year":"2005","journal-title":"ASHA Leader"},{"key":"10.1016\/j.jctube.2021.100229_b0095","doi-asserted-by":"crossref","unstructured":"Clemens, E., et al., A comparison of the Muenster, SIOP Boston, Brock, Chang and CTCAEv4. 03 ototoxicity grading scales applied to 3,799 audiograms of childhood cancer patients treated with platinum-based chemotherapy. 2019. 14(2): p. e0210646.","DOI":"10.1371\/journal.pone.0210646"},{"key":"10.1016\/j.jctube.2021.100229_b0100","doi-asserted-by":"crossref","unstructured":"Harris, T., et al., Audiological monitoring for ototoxic tuberculosis, human immunodeficiency virus and cancer therapies in a developing world setting. 2012. 126(6): p. 548-551.","DOI":"10.1017\/S0022215112000357"},{"issue":"1","key":"10.1016\/j.jctube.2021.100229_b0105","doi-asserted-by":"crossref","DOI":"10.1186\/s40360-015-0036-7","article-title":"Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort","volume":"16","author":"Sagwa","year":"2015","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.jctube.2021.100229_b0110","doi-asserted-by":"crossref","unstructured":"Ramma, L. and T.S.J.I.a.o.m. Ibekwe, Cochleo-vestibular clinical findings among drug resistant Tuberculosis Patients on therapy-a pilot study. 2012. 5(1): p. 3.","DOI":"10.1186\/1755-7682-5-3"},{"issue":"1","key":"10.1016\/j.jctube.2021.100229_b0115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1472-6815-7-5","article-title":"Audiologic monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-up","volume":"7","author":"Duggal","year":"2007","journal-title":"BMC Ear, Nose Throat Disorders"},{"key":"10.1016\/j.jctube.2021.100229_b0120","doi-asserted-by":"crossref","unstructured":"Stavroulaki, P., et al., Otoacoustic emissions for monitoring aminoglycoside-induced ototoxicity in children with cystic fibrosis. 2002. 128(2): p. 150-155.","DOI":"10.1001\/archotol.128.2.150"},{"key":"10.1016\/j.jctube.2021.100229_b0125","unstructured":"Jacobson, E.J., M.P. Downs, and J.L.J.J.o.A.R. Fletcher, Clinical findings in high-frequency thresholds during known ototoxic drug usage. 1969."}],"container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579421000188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579421000188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:36:18Z","timestamp":1762500978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405579421000188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":25,"alternative-id":["S2405579421000188"],"URL":"https:\/\/doi.org\/10.1016\/j.jctube.2021.100229","relation":{},"ISSN":["2405-5794"],"issn-type":[{"value":"2405-5794","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Audiological monitoring of patients undergoing multidrug resistant tuberculosis treatment at Jigme Dorji Wangchuk National Referral Hospital and Gidakom Hospital, Bhutan","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jctube.2021.100229","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100229"}}